中国医师进修杂志
中國醫師進脩雜誌
중국의사진수잡지
CHINESE JOURNAL OF POSTGRADUATES OF MEDICINE
2010年
34期
6-9
,共4页
丁元伟%吴婉清%陈德%刘卉%严志强%吕建忠%杨涛%甘静娣
丁元偉%吳婉清%陳德%劉卉%嚴誌彊%呂建忠%楊濤%甘靜娣
정원위%오완청%진덕%류훼%엄지강%려건충%양도%감정제
肠易激综合征%焦虑%抑郁
腸易激綜閤徵%焦慮%抑鬱
장역격종합정%초필%억욱
Irritable bowel syndrome%Anxiety%Depression
目的 研究联用氟哌噻吨美利曲辛和匹维溴铵对伴有焦虑抑郁状态腹泻型肠易激综合征(IBS-D)直肠动力与直肠感觉功能的影响.方法 44例伴有焦虑抑郁状态IBS-D患者按随机数字表法分为联用氟哌噻吨美利曲辛和匹维溴铵组(A组)和单用匹维溴铵组(B组),以25例健康体检者作为对照组.对两组患者服药前后直肠动力与直肠感觉功能进行检测对比.结果 服药前A组增加腹压肛门括约肌净增压为(3.0±1.2)kPa,B组为(2.9±1.2)kPa,均低于对照组的(3.6±1.6)kPa(P<0.05);A组直肠最低敏感量、最大耐受量、最大顺应性分别为(55±20)ml、(145±78)ml、(21.9±12.9)ml/kPa,B组分别为(56±38)ml、(150±50)ml、(20.8±11.2)ml/kPa,均明显低于对照组的(80±38)ml、(190±50)ml、(30.8±15.2)ml/kPa(P<0.01).服药后A组直肠最低敏感量、最大耐受量、最大顺应性均高于服药前(P<0.01或<0.05);B组仅直肠最低敏感量高于服药前(P<0.05);A组直肠最低敏感量、最大耐受量、最大顺应性均高于B组(P<0.05或<0.01).结论 IBS-D患者直肠对容量刺激存在高敏感、低耐受、低顺应性和肛门自控能力减弱.联用氟哌噻吨美利曲辛和匹维溴铵治疗伴有焦虑抑郁状态IBS-D能更有效地改善直肠感觉功能.
目的 研究聯用氟哌噻噸美利麯辛和匹維溴銨對伴有焦慮抑鬱狀態腹瀉型腸易激綜閤徵(IBS-D)直腸動力與直腸感覺功能的影響.方法 44例伴有焦慮抑鬱狀態IBS-D患者按隨機數字錶法分為聯用氟哌噻噸美利麯辛和匹維溴銨組(A組)和單用匹維溴銨組(B組),以25例健康體檢者作為對照組.對兩組患者服藥前後直腸動力與直腸感覺功能進行檢測對比.結果 服藥前A組增加腹壓肛門括約肌淨增壓為(3.0±1.2)kPa,B組為(2.9±1.2)kPa,均低于對照組的(3.6±1.6)kPa(P<0.05);A組直腸最低敏感量、最大耐受量、最大順應性分彆為(55±20)ml、(145±78)ml、(21.9±12.9)ml/kPa,B組分彆為(56±38)ml、(150±50)ml、(20.8±11.2)ml/kPa,均明顯低于對照組的(80±38)ml、(190±50)ml、(30.8±15.2)ml/kPa(P<0.01).服藥後A組直腸最低敏感量、最大耐受量、最大順應性均高于服藥前(P<0.01或<0.05);B組僅直腸最低敏感量高于服藥前(P<0.05);A組直腸最低敏感量、最大耐受量、最大順應性均高于B組(P<0.05或<0.01).結論 IBS-D患者直腸對容量刺激存在高敏感、低耐受、低順應性和肛門自控能力減弱.聯用氟哌噻噸美利麯辛和匹維溴銨治療伴有焦慮抑鬱狀態IBS-D能更有效地改善直腸感覺功能.
목적 연구련용불고새둔미리곡신화필유추안대반유초필억욱상태복사형장역격종합정(IBS-D)직장동력여직장감각공능적영향.방법 44례반유초필억욱상태IBS-D환자안수궤수자표법분위련용불고새둔미리곡신화필유추안조(A조)화단용필유추안조(B조),이25례건강체검자작위대조조.대량조환자복약전후직장동력여직장감각공능진행검측대비.결과 복약전A조증가복압항문괄약기정증압위(3.0±1.2)kPa,B조위(2.9±1.2)kPa,균저우대조조적(3.6±1.6)kPa(P<0.05);A조직장최저민감량、최대내수량、최대순응성분별위(55±20)ml、(145±78)ml、(21.9±12.9)ml/kPa,B조분별위(56±38)ml、(150±50)ml、(20.8±11.2)ml/kPa,균명현저우대조조적(80±38)ml、(190±50)ml、(30.8±15.2)ml/kPa(P<0.01).복약후A조직장최저민감량、최대내수량、최대순응성균고우복약전(P<0.01혹<0.05);B조부직장최저민감량고우복약전(P<0.05);A조직장최저민감량、최대내수량、최대순응성균고우B조(P<0.05혹<0.01).결론 IBS-D환자직장대용량자격존재고민감、저내수、저순응성화항문자공능력감약.련용불고새둔미리곡신화필유추안치료반유초필억욱상태IBS-D능경유효지개선직장감각공능.
Objective To study the effect of flupentioxl melitracen and pinaverium bromide treatment on the changes of anorectal motility and rectal sensation in the patients of diarrhea-predominant irritable bowel syndrome (IBS-D) accompanying with depression and/or anxiety status. Methods Forty-four patients with IBS-D accompanying with depression and/or anxiety status were divided into group A (flupentioxl melitracen and pinaverium bromide) and group B (pinaverium bromide) by random digits table,and treated for 4 weeks. Twenty-five healthy subjects were included as control group. The anorectal motility and rectal sensation before and after taking medicines were compared. Results When abdominal pressure was increased, the net increased pressure of anal sphincter was (3.0 ± 1.2 ) kPa in group A and (2.9 ± 1.2)kPa in group B. They were lower than that in control group [(3.6 ± 1.6) kPa](P< 0.05). The rectal lowest volume of sensory threshold, the maximal volume of tolerance and maximal compliance were (55 ± 20) ml,( 145 ± 78 ) ml, ( 21.9 ± 12.9 ) ml/kPa in group A, ( 56 ± 38 ) ml, ( 150 ± 50 ) ml, (20.8 ± 11.2) ml/kPa in group B. They were lower than those in control group [(80 ± 38 ) ml, ( 190 ± 50 ) ml, (30.8 ± 15.2 ) ml/kPa](P < 0.01 ). The rectal lowest volume of sensory threshold, the maximal volume of tolerance and maximal compliance were higher than those before taking medicines. Only the rectal lowest volume of sensory threshold in group B was higher than that before taking medicines. The rectal lowest volume of sensory threshold, the maximal volume of tolerance and maximal compliance in group A after taking medicines were higher than those in group B (P < 0.05 or < 0.01 ). Conclusions Higher sensitivity, lower tolerance,lower compliance of rectum and weakened anal automatic control function in IBS-D may be associated with diarrhea and frequent defecation. Treatment combining flupentioxl melitracen with pinaverium bromide may preferably improve the aperception functions of rectum in the patients of IBS-D accompanying with depression and/or anxiety status.